home / stock / clpt / clpt quote
Last: | $5.585 |
---|---|
Change Percent: | 2.67% |
Open: | $5.45 |
Close: | $5.44 |
High: | $5.65 |
Low: | $5.39 |
Volume: | 88,008 |
Last Trade Date Time: | 07/08/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.585 | $5.45 | $5.44 | $5.65 | $5.39 | 88,008 | 07-08-2024 |
$5.44 | $5.37 | $5.44 | $5.5399 | $5.29 | 143,067 | 07-05-2024 |
$5.37 | $5.32 | $5.37 | $5.4832 | $5.24 | 76,208 | 07-04-2024 |
$5.37 | $5.32 | $5.37 | $5.4832 | $5.24 | 76,208 | 07-03-2024 |
$5.3 | $5.31 | $5.3 | $5.3999 | $5.11 | 264,178 | 07-02-2024 |
$5.33 | $5.42 | $5.33 | $5.8356 | $5.31 | 370,310 | 07-01-2024 |
$5.39 | $5.65 | $5.39 | $5.695 | $5.29 | 2,981,639 | 06-28-2024 |
$5.68 | $5.58 | $5.68 | $5.87 | $5.4 | 276,256 | 06-27-2024 |
$5.52 | $5.54 | $5.52 | $5.89 | $5.44 | 201,376 | 06-26-2024 |
$5.59 | $5.49 | $5.59 | $5.61 | $5.39 | 153,813 | 06-25-2024 |
$5.51 | $5.73 | $5.51 | $5.73 | $5.49 | 90,040 | 06-24-2024 |
$5.65 | $5.53 | $5.65 | $5.73 | $5.42 | 243,022 | 06-21-2024 |
$5.54 | $5.25 | $5.54 | $5.69 | $5.25 | 179,272 | 06-20-2024 |
$5.25 | $5.35 | $5.25 | $5.54 | $5.21 | 130,130 | 06-19-2024 |
$5.25 | $5.35 | $5.25 | $5.54 | $5.21 | 130,130 | 06-18-2024 |
$5.39 | $5.38 | $5.39 | $5.44 | $5.24 | 163,984 | 06-17-2024 |
$5.41 | $5.62 | $5.41 | $5.63 | $5.32 | 252,365 | 06-14-2024 |
$5.72 | $5.73 | $5.72 | $5.89 | $5.63 | 147,272 | 06-13-2024 |
$5.66 | $5.94 | $5.66 | $5.9843 | $5.62 | 163,321 | 06-12-2024 |
$5.74 | $5.77 | $5.74 | $5.8 | $5.45 | 148,992 | 06-11-2024 |
News, Short Squeeze, Breakout and More Instantly...
ClearPoint Neuro, Inc. Company Name:
CLPT Stock Symbol:
NASDAQ Market:
ClearPoint Neuro, Inc. Website:
SOLANA BEACH, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today congratulates its partner Aspen Neuroscience, Inc. on use...
Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons PR Newswire Aspen Neuroscience Announces MRI-Guided Transplantation Approach for ASPIRO Clinical Trial with the ClearPoint®...
SOLANA BEACH, Calif., June 01, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announces full market release of its SmartFrame OR platfo...